BioSpace News Archive

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced that the U.S. Food and Drug Administration has granted Fast Track designation to AT-007 for the treatment of Galactosemia, a rare metabolic disease.

FibroGen, Inc. and HiFiBiO Therapeutics, a private, multinational clinical-stage biotherapeutics company with expertise in immune modulation and single cell science announced a partnership covering three HiFiBiO programs.

Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis platform for quantifying the proteome, announced the appointment of Emma Lundberg, Ph.D. to its Scientific Advisory Board.

CareDx, Inc. announced that Reg Seeto, President and CEO of CareDx, will present “Improving Access to Transplant Care:Telehealth & Technology to Enable Patients Along the Transplant Journey,” at the American Association of Kidney Patients 4th Annual Policy Summit, which will be held virtually on June 17, 2021.

Creative Medical Technology Holdings, Inc., announced that the company will virtually present at the Investor Forum at the World Stem Cell Summit Thursday, June 17, 2021 at 12:00pm Eastern Standard Time and will consist of a 20-minute formal description of the Company followed by a 20-minute Q&A session moderated by a Noble Capital Markets equity research representative.

Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate therapies for multiple oncology indications, announced the formation of a new, urologic oncology focused Scientific Advisory Board.

Immunome, Inc., a biopharmaceutical company that utilizes its human memory B cell discovery engine platform to discover and develop first-in-class antibody therapeutics, announced the appointment of Franklyn G. Prendergast, M.D., Ph.D., to its Board of Directors.

Taysha Gene Therapies, Inc., a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations, announced that it will host its first two-day virtual research and development day for analysts and investors.

The global teleradiology software market is anticipated to witness healthy growth during the forecast period 2021-2031, finds Fact.MR in a study.

Ebola has emerged as a major hazard to mankind in recent years. Though the Ebola virus and the disease caused by it have been familiar to science for decades, the risk of a global epidemic has increased massively due to the advances in globalization.